Cargando…

Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease worldwide, but a reliable non-invasive method to quantify liver steatosis in primary healthcare is not available. Circulating microRNAs have been proposed as biomarkers of severe/advanced NAFLD (steatohepat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintás, Guillermo, Caiment, Florian, Rienda, Iván, Pérez-Rojas, Judith, Pareja, Eugenia, Castell, José V., Jover, Ramiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408888/ https://www.ncbi.nlm.nih.gov/pubmed/36012565 http://dx.doi.org/10.3390/ijms23169298

Ejemplares similares

Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients
por: Pérez-Rubio, Álvaro, et al.
Publicado: (2023)

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease
por: López-Riera, Mireia, et al.
Publicado: (2017)

Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver
por: Moya, Marta, et al.
Publicado: (2012)

Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk
por: Pasmans, Kenneth, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice
por: Park, Mi-Young, et al.
Publicado: (2013)

Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet
por: Song, Lihua, et al.
Publicado: (2017)

Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers
por: López-Riera, Mireia, et al.
Publicado: (2018)

Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content
por: De Robertis, Riccardo, et al.
Publicado: (2023)

Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis
por: Zhou, Peng, et al.
Publicado: (2014)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Effects of soy isoflavone on hepatic steatosis in high fat-induced rats
por: Liu, Huanhuan, et al.
Publicado: (2017)

Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
por: Zhang, Hanlin, et al.
Publicado: (2021)

Corrigendum: Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet
por: Song, Lihua, et al.
Publicado: (2017)

Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease
por: Nishimiya, Noriko, et al.
Publicado: (2021)

Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease
por: Sim, Ki Choon, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Co‐regulation of hepatic steatosis by ferritinophagy and unsaturated fatty acid supply
por: Li, Ning, et al.
Publicado: (2022)

Fatty Acid Excess Dysregulates CARF to Initiate the Development of Hepatic Steatosis
por: Hasan, Kamrul M., et al.
Publicado: (2023)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs
por: Dai, Wencong, et al.
Publicado: (2015)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet
por: Li, Xiumin, et al.
Publicado: (2013)

Hypoxia Suppresses High Fat Diet-Induced Steatosis And Development Of Hepatic Adenomas
por: Sweeney, Nathan W, et al.
Publicado: (2019)

Effect of Adrenergic Agonists on High-Fat Diet-Induced Hepatic Steatosis in Mice
por: Nakade, Yukiomi, et al.
Publicado: (2020)

Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice
por: Ye, Jiena, et al.
Publicado: (2022)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
por: Jiang, Meng, et al.
Publicado: (2019)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
por: Ogino, Yu, et al.
Publicado: (2021)

Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density
por: Xie, Ruijie, et al.
Publicado: (2022)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ermeep94f44fllsb0pori7ek8s